Skip to content
Healthy Aging Hub

:

Articles related to focusing on healthy aging, prevention, mobility, cognition, nutrition, independence, and caregiving support.

2 min

Understanding What are the clinical outcomes in elderly patients receiving agalsidase alfa treatment in the Fabry outcome survey?

According to research published in Molecular Genetics and Metabolism Reports, long-term agalsidase alfa treatment can provide renal, cardiac, and overall survival protection in Fabry disease. A specific analysis focusing on older adults provides further detail on **what are the clinical outcomes in elderly patients receiving agalsidase alfa treatment in the Fabry outcome survey?**

Read Healthy Aging
5 min

What is the HoNOS 65+ score? A guide to this clinical tool

According to the Royal College of Psychiatrists, the original HoNOS 65+ score was first published in 1999 to specifically address the needs of older people in mental health services. This authoritative assessment tool was adapted to measure particular physical and cognitive problems, including psychiatric symptoms and psychosocial functioning.

Read Healthy Aging